Beit Jala Pharmaceutical Company announced audited earnings results for the year ended December 31, 2017. For the year, the company reported sales of JOD 8,323,963 against JOD 7,819,715 a year ago. Net income before tax was JOD 1,781,456 against JOD 2,067,095 a year ago. Net income after tax was JOD 1,645,697 against JOD 1,924,748 a year ago. Basic and diluted earnings per share were JOD 0.235 against JOD 0.275 a year ago. Net cash flow from operating activities was JOD 2,552,990 against JOD 3,019,557 a year ago. Purchase of property, plant and equipment was JOD 982,524 against JOD 1,959,969 a year ago.